Personalized Digital Healthcare for Managing Treatment Side Effects in Breast Cancer Survivors Aged 18 to 65

What this Trial Is About

Researchers are evaluating personalized digital healthcare technologies and self-management strategies for breast cancer survivors who need help managing side effects from treatments like surgery, chemotherapy, radiation, and hormone therapy. The study aims to verify clinical usefulness and develop a service model to meet the diverse healthcare needs of these survivors. This trial is interventional and led by Samsung Medical Center, focusing on improving recovery and management of treatment-related side effects. Participants are randomly assigned to one of two groups a control group receiving conventional treatment plus brochure training, or an intervention group receiving the same plus digital health tools, including an application and smartwatch. The app helps users self-assess symptoms and side effects and provides personalized self-management strategies along with features for exercise, diet, and weight management. The study includes a six-month period with assessments at baseline, month 1, month 3, and month 6. During the study, participants will complete various evaluations such as the PROMIS29, EQ-5D-5L, PRO-CTCAE, and body composition measurements, among others, at scheduled intervals. Researchers will monitor activity levels via step counts and assess behavioral changes using questionnaires. Safety and adherence are tracked throughout. The total participation lasts six months, with multiple assessments to measure health outcomes and recovery progress.

Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors